Home
About
Overview
Sharing Data
ORCID
Help
History (20)
PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.
Outcomes of transcatheter aortic valve replacement in patients with mitral annular calcification and concomitant mitral valve dysfunction: A systematic review and meta-analysis.
Magnetic resonance contrast agents in optical clearing: Prospects for multimodal tissue imaging.
Psychopharmacology
Identifying patients likely to be readmitted after transcatheter aortic valve replacement.
See All 20 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Identifying patients likely to be readmitted after transcatheter aortic valve replacement.
Goldsweig A, Aronow HD. Identifying patients likely to be readmitted after transcatheter aortic valve replacement. Heart. 2020 02; 106(4):256-260.
View in:
PubMed
subject areas
Acute Kidney Injury
Anticoagulants
Aortic Valve Insufficiency
Aortic Valve Stenosis
Atrial Fibrillation
Cardiac Pacing, Artificial
Chronic Disease
Hospitals
Hospitals, Teaching
Humans
Length of Stay
Lung Diseases
Pacemaker, Artificial
Patient Readmission
Platelet Aggregation Inhibitors
Postoperative Complications
Renal Insufficiency, Chronic
Risk Assessment
Risk Factors
Sex Factors
Stroke Volume
Transcatheter Aortic Valve Replacement
Tricuspid Valve Insufficiency
Ventricular Dysfunction, Left
authors with profiles
Andrew Goldsweig MD, MS